APA (7th ed.) Citation

Polistena, B., Provenzano, A. M., Rizzi, C., Colombo, E., & Bergamaschi, R. (2025). Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy. Neurology & Therapy, 14(4), 1507. https://doi.org/10.1007/s40120-025-00761-7

Chicago Style (17th ed.) Citation

Polistena, Barbara, Anna Maria Provenzano, Caterina Rizzi, Elena Colombo, and Roberto Bergamaschi. "Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy." Neurology & Therapy 14, no. 4 (2025): 1507. https://doi.org/10.1007/s40120-025-00761-7.

MLA (9th ed.) Citation

Polistena, Barbara, et al. "Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy." Neurology & Therapy, vol. 14, no. 4, 2025, p. 1507, https://doi.org/10.1007/s40120-025-00761-7.